IL15 and neoplasm: The manganese superoxide dismutase (MnSOD) or immunostimulatory cytokines (such as IL-21, IL-15) expressing oncolytic VACVs could also improve PD-1/PD-L1 inhibition outcome by remodeling the suppressive tumor microenvironment (89–91).